COVID-19 impacts patient screening and enrollment
First US & Asia patient will be enrolled in the RELEASE study H2/20
Study progress delayed and increased costs are expected
Major trigger will be deal/no deal with AstraZeneca, update in June
06 May 2020
Study progression behind schedule
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Study progression behind schedule
COVID-19 impacts patient screening and enrollment
First US & Asia patient will be enrolled in the RELEASE study H2/20
Study progress delayed and increased costs are expected
Major trigger will be deal/no deal with AstraZeneca, update in June